Recent Finacing
Recent Raise
Periphagen Holdings develops an HSV-based gene therapy platform and operates as a clinical-stage biopharmaceutical company advancing gene therapies for diseases with significant unmet medical need.
Focus Areas
Total Raised
Funding round